One Stop Solution For In-Depth Market Research Reports

詳細な市場調査レポートのワンストップソリューション

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Adhesion Barrier Market

[ 英語タイトル ] Adhesion Barrier Market by Product (Regenerated Cellulose, Hyaluronic Acid, Polyethylene Glycol, Fibrin, Collagen & Protein), Type (Film, Gel, Liquid), Application (Abdominal, Orthopedic, Cardiovascular, Gynecological Surgery) - Global Forecast to 2023


Product Code : MNMHC00109821
Survey : MarketsandMarkets
Publish On : April, 2021
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD5650 / Question Form
5 User USD6650 / Question Form
Enterprise User USD10000 / Question Form

[Report Description]

The adhesion barrier market is projected to reach to USD 806.4 million by 2023 from estimated USD 570.7 million in 2018. Factors such as rising geriatric population, increase in the volume of surgeries and sports related-injuries, and increasing awarness about the medical implications of adhesion are expected to drive the growth of this market during the forecast period of 2018 to 2023. However, reluctance among surgeons towards the usgage of adhesion barriers and the stringent regulations resulting in limited technological innovations may challenge market growth to a certain extent in the coming years.

The hyaluronic acid segment is projected to witness the highest growth during the forecast period
Based on the type, the synthetic adhesion barrier market is further classified into hyaluronic acid, regenerated cellulose, polyethylene glycol (PEG), and other synthetic adhesion barriers (such as combination products of polyethylene oxide and carboxymethylcellulose, icodextrin, silicone rubber, expanded polytetrafluorethylene (ePTFE) membrane, and hydrogel). The hyaluronic acid segment is expected to grow at the highest CAGR during the forecast period. Growth in this market is driven by the growing preference for hyaluronic acid-based adhesion barriers among surgeons.

The gel formulation is expected to grow at the highest CAGR during the forecast period
On the basis of formulations, the adhesion barrier market is segmented into film, liquid, and gel formulations. During the forecast period, the gel formulations segment is expected to grow at the highest CAGR. Growth in this segment is due to the growth in the demand and preference for gel-form adhesion barriers among end users.

The neurological surgeries segment is expected to register the highest CAGR during the forecast period
Based on applications, the adhesion barriers market is segmented into gynecological surgeries, general/abdominal surgeries, cardiovascular surgeries, orthopedic surgeries, neurological surgeries, reconstructive surgeries, urological surgeries, and other surgeries (such as ear, nose, throat, and burn surgeries). The neurological surgeries segment is estimated to register the highest CAGR during the forecast period. The growth of this segment is driven by the increasing focus of players on developing adhesion barrier gels for neurological surgeries.

Asia Pacific to witness the highest growth during the forecast period
Asia Pacific is expected to witness the highest growth during the forecast period (2018 to 2023). The region’s large geriatric population, large patient population, improving healthcare infrastructure, growing medical tourism, and epidemiological shift from infectious to chronic diseases are driving the growth of this market.

Break of primary participants from supply side was as mentioned below:
• By Company Type – Tier 1–42%, Tier 2–35% and Tier 3–23%
• By Designation – C Level–28%, Director Level–35%, Others–37%
• By Region – North America–35%, Europe–25%, Asia Pacific–19%, Latin America- 11%, Middle East and Africa–10%

Break of primary participants from demand side was as mentioned below:
• By Type of Facility–Hospitals and Surgery Centers–75%, and Academic & Research Institutes–25%
• By Designation – General & Specialty Surgeons –45%, Hospital & Surgical Centers’ Managers–20%, Hospital Directors & VPs–10%, and Others -25%
• By Region – North America–40%, Europe–35%, Asia Pacific–10%, Latin America- 10%, Middle East and Africa–5%
Some of the major market players in the adhesion barrier market are Johnson & Johnson (J&J) (US), Sanofi (France), Baxter International (US), C.R. Bard (US), Integra LifeSciences (US), Anika Therapeutics (US), Atrium Medical Corporation (US), FzioMed (US), MAST Biosurgery (Switzerland), Innocoll Holdings (Ireland), Betatech Medical (Turkey), SyntheMed (US), Aziyo Biologics (US), Biom’up (France), Terumo Corporation (Japan), and BMI Korea Co. (South Korea).
Research Coverage:
The report analyzes the adhesion barrier market and aims at estimating the market size and future growth potential of this market based on various segments such as product, formulation, application, and region. The report also includes a product portfolio matrix and product pipeline analysis of adhesion barriers available in the market and are under one of the clinical trial phases respectively. The report also provides competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a greater share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:
• Market Penetration: Comprehensive information on product portfolios offered by the top players in the global adhesion barrier market. The report analyzes this market by product, formulation, application, and region.
• Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global adhesion barrier market
• Market Development: Comprehensive information on the lucrative emerging markets by product, formulation, application, and region
• Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global adhesion barrier market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of leading players in the global adhesion barrier market

TABLE OF CONTENTS

1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 16
1.3 SCOPE OF THE STUDY 17
1.3.1 MARKETS COVERED 17
1.3.2 YEARS CONSIDERED FOR THE STUDY 17
1.4 CURRENCY 18
1.5 LIMITATIONS 18
1.6 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH DATA 19
2.1.1 SECONDARY DATA 20
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY DATA 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Key industry insights 24
2.2 MARKET SIZE ESTIMATION 25
2.2.1 BOTTOM-UP APPROACH 26
2.2.2 TOP-DOWN APPROACH 26
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 27
2.4 MARKET SHARE ESTIMATION 28
2.5 ASSUMPTIONS FOR THE STUDY 28
3 EXECUTIVE SUMMARY 29
4 PREMIUM INSIGHTS 33
4.1 GROWTH POTENTIAL OF THE ADHESION BARRIERS MARKET 33
4.2 ASIA PACIFIC SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE 34
4.3 ADHESION BARRIERS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 35
4.4 ADHESION BARRIERS MARKET, BY REGION 36
4.5 ADHESION BARRIERS MARKET: DEVELOPING VS. DEVELOPED COUNTRIES 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 37
5.2.1 DRIVERS 38
5.2.1.1 Rising geriatric population 38
5.2.1.2 Increase in the volume of surgeries and sports-related injuries 38
5.2.1.3 Increasing awareness about the medical implications of adhesions 39
5.2.2 RESTRAINTS 40
5.2.2.1 Reluctance towards the usage of adhesion barriers among surgeons 40
5.2.3 OPPORTUNITIES 40
5.2.3.1 Untapped emerging markets 40
5.2.4 CHALLENGES 41
5.2.4.1 Stringent regulations resulting in limited technological innovations 41
6 INDUSTRY INSIGHTS 42
6.1 INDUSTRY TRENDS 42
6.1.1 RISING FOCUS ON GEL-FORM ADHESION BARRIERS FOR SURGERIES 42
6.2 PRODUCT PIPELINE ANALYSIS 42
6.3 REGULATORY ANALYSIS 43
6.3.1 NORTH AMERICA 44
6.3.1.1 US 44
6.3.1.2 Canada 45
6.3.2 EUROPE 47
6.3.3 APAC 47
6.3.3.1 Japan 47
6.3.3.2 China 48
6.3.3.3 India 49
7 ADHESION BARRIERS MARKET, BY PRODUCT 50
7.1 INTRODUCTION 51
7.2 SYNTHETIC ADHESION BARRIERS 52
7.2.1 HYALURONIC ACID 54
7.2.2 REGENERATED CELLULOSE 55
7.2.3 POLYETHYLENE GLYCOL 56
7.2.4 OTHER SYNTHETIC ADHESION BARRIERS 57
7.3 NATURAL ADHESION BARRIERS 59
7.3.1 COLLAGEN & PROTEIN 60
7.3.2 FIBRIN 61
8 ADHESION BARRIERS MARKET, BY FORMULATION 63
8.1 INTRODUCTION 64
8.2 FILM FORMULATIONS 65
8.3 LIQUID FORMULATIONS 67
8.4 GEL FORMULATIONS 68

9 ADHESION BARRIERS MARKET, BY APPLICATION 70
9.1 INTRODUCTION 71
9.2 GYNECOLOGICAL SURGERIES 72
9.3 GENERAL/ABDOMINAL SURGERIES 74
9.4 CARDIOVASCULAR SURGERIES 75
9.5 ORTHOPEDIC SURGERIES 77
9.6 NEUROLOGICAL SURGERIES 78
9.7 RECONSTRUCTIVE SURGERIES 79
9.8 UROLOGICAL SURGERIES 80
9.9 OTHER SURGERIES 81
10 ADHESION BARRIERS MARKET, BY REGION 82
10.1 INTRODUCTION 83
10.2 NORTH AMERICA 85
10.2.1 US 89
10.2.2 CANADA 93
10.3 EUROPE 96
10.3.1 GERMANY 99
10.3.2 FRANCE 102
10.3.3 UK 104
10.3.4 ITALY 107
10.3.5 SPAIN 110
10.3.6 REST OF EUROPE 113
10.4 ASIA PACIFIC 116
10.4.1 JAPAN 120
10.4.2 CHINA 123
10.4.3 INDIA 126
10.4.4 REST OF ASIA PACIFIC 128
10.5 LATIN AMERICA 132
10.5.1 BRAZIL 135
10.5.2 MEXICO 138
10.5.3 REST OF LATIN AMERICA 141
10.6 MIDDLE EAST AND AFRICA 144
11 COMPETITIVE LANDSCAPE 147
11.1 INTRODUCTION 147
11.2 PRODUCT PORTFOLIO MATRIX 148
11.3 GEOGRAPHICAL REVENUE MIX (2017) 148
11.4 MARKET SHARE ANALYSIS 149
11.5 COMPETITIVE SITUATIONS AND TRENDS 150
11.5.1 ACQUISITIONS 150
11.5.2 EXPANSION 150
11.5.3 PATENT/REGULATORY APPROVALS 150
12 COMPANY PROFILES 151
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 JOHNSON & JOHNSON 151
12.2 SANOFI 154
12.3 BAXTER INTERNATIONAL 156
12.4 C. R. BARD 158
12.5 INTEGRA LIFESCIENCES HOLDINGS CORPORATION 161
12.6 ANIKA THERAPEUTICS 164
12.7 ATRIUM MEDICAL CORPORATION (A PART OF GETINGE GROUP) 166
12.8 FZIOMED 168
12.9 MAST BIOSURGERY 170
12.10 INNOCOLL HOLDINGS 171
12.11 BETATECH MEDICAL 172

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
13 APPENDIX 173
13.1 INSIGHTS OF INDUSTRY EXPERTS 173
13.2 DISCUSSION GUIDE 174
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 178
13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 180
13.5 AVAILABLE CUSTOMIZATIONS 181
13.6 RELATED REPORTS 182
13.7 AUTHOR DETAILS 183

渋谷データカウント

渋谷データカウントは、最も信頼性が高く最新の調査分析レポートを確実に提供する経験豊富な調査専門家のグローバルチームが提供する、さまざまな業界のさまざまな市場調査レポートを提供する再販代理店です。

Recommended reports

+